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Literature Review 
  
As medical scientific technologies evolve, numerous medical tests help not only 
physicians with their clinical judgment, but also patients by empowering them with more 
knowledge of their own health. An example is Genetic Carrier Screening (GCS) [1-2]. 
Genetic Carrier Screening (GCS) is a genetic test that allows patients to find out if 
they carry genes for certain genetic disorders. The results of the test enable patients to 
make changes to their family planning decisions and prenatal care when appropriate and 
allow them the opportunity to seek further medical and social support [3]. The clinical 
utility of GCS is evident in the significant decrease in the number of Tay-Sachs disease 
incidences between 1970 and 2000 (a 90% decrease) and decreases in the number of 
newborns born with cystic fibrosis and thalassemia since the development of GCS in 
1970s [4-7]. 
Despite these health benefits and notable clinical utility of GCS, GCS has not 
been utilized in most nations due to moral and ethical controversy among the public [8-
12]. Certain populations have shown to have positive attitudes toward GCS, such as those 
who have a higher risk of having severe recessive disorders. African Americans, for 
example, are supportive of sickle cell carrier screening [13-15]. Also, the majority of 
cystic fibrosis patients and their family members support the practice of GCS [16-19]. 
However, others fear that GCS might result in unnecessary feelings of guilt and a greater 
burden to parents [17]. 
Other factors have been shown to be associated with attitudes and intentions 
towards GCS, even within at risk populations. One study demonstrated that among 
African American patients, their socio-demographic factors (age, education), previous 
screening knowledge, and the presence of perceived threat were associated with the 
patient’s intention to undergo GCS for sickle cell trait screening [20]. In cystic fibrosis 
patients, other studies have shown that socioeconomic status, ethnicity and sex affected 
patients’ decisions to accept GCS [21-27]. 
There are limited studies that address factors that affect the decision-making 
process of the general public for GCS. One study examined the impression and attitudes 
about preconception GCS among 468 OB-GYN female patients in Montgomery County, 
OH. The study showed that although patients believed that it would be beneficial to know 
their carrier status and that it is their responsibility to undergo testing, they did not want 
to go through GCS [28]. That study did not investigate the socioeconomic and 
demographic factors that may have impacted the decision to choose GCS among this 
population. Therefore, the objective of this study is to describe socioeconomic and 
demographic factors affecting these female patients’ desire to undergo GCS.  
 
Hypothesis/Specific Aims/Research Questions  
  
This paper explores the socioeconomic and demographic factor differences 
between patients who desire to undergo GCS and patients who do not desire to undergo 
GCS, and their respective correlations.  
Socioeconomic factors that will be examined in this study are types of medical 
insurance and highest level of education. Demographic factors include age and religious 
affiliation. 
 I hypothesize that patients with higher education (some college and beyond) and 
private insurance are more willing to undergo GCS. In regards to the demographic 
factors, I hypothesize that older patients are more willing to go through GCS and that 
patients with religious beliefs are less likely to undergo GCS.  
 
Methodology 
 
Context  
 
This is a secondary data analysis of the data collected in the study that examined 
attitudes of 468 OB-GYN female patients in Montgomery County, OH toward GCS [28]. 
Data for the OB-GYN patients in Montgomery County study was collected via an 
anonymous survey distributed to 468 patients attending OB/GYN visits at Wright State 
Physicians and at Five Rivers Center for Women’s Health from July 2015 to August 
2016. Survey respondents included patients who are currently pregnant, and those 
considering future fertility or currently undergoing fertility treatment. Participants were 
over 18 years old and able to understand and write in English. All responses were 
collected via convenience sampling of a self-administered survey containing a front page 
with consent information. The final sample for analysis was 468 women. 
 
Data Collection 
 
A descriptive self-administered survey composed of 31 questions was distributed 
to the subjects, who completed and returned the survey at the physician’s office. The 
questionnaire was designed to gauge participants’ attitudes and perspectives regarding 
GCS with both closed and open-ended questions. The survey questions include patient 
demographics (age, gender, ethnicity and religious preferences), socioeconomics (highest 
level of education and type of health insurance), and questions to measure patient 
opinions on GCS (positive or negative attitudes towards GCS, desire to undergo GCS, 
and how much a patient would be willing to pay to have GCS, etc.) For my study, I will 
focus on associations between patients’ age, religious affiliation, highest level of 
education, type of health insurance, and their desire to go through GCS. 
The independent variables of interest include socioeconomic factors such 
as highest level of education and type of health insurance and demographic factors such 
as patients’ age and religious affiliation. Patients’ education levels were subdivided into 
the following three categories: high school/GED, some college, and graduate 
school/doctorate level. They were also classified on the basis of religious affiliation. 
Religious affiliation was classified into Christian, Judaism, Islam, Buddhism, 
Hinduism, Jehovah’s Witness, no religious affiliation and other. For the purpose of this 
study, I will simply classify religion as “religiously affiliated” and “no religious 
affiliation.” Type of health insurance that the individuals have were recorded as 
“Private,” “Medicaid,” and “Self-pay/none.” Participants’ age was measured as a 
continuous variable in which they simply answered with a number. However, I will 
divide the variable into three age groups, namely, 18-28, 29-36, and 37+.   
The dependent variable is individuals’ desire to go through GCS. Participants 
were asked to answer the question, “Do you desire to undergo Genetic Carrier 
Screening?” with “Yes” and “No” as answer choices. 
No power analysis was done because my study is a secondary data analysis. 
Therefore, the available data set is predetermined. 
 
Data Analysis 
  
This is a retrospective quantitative analysis of existing survey data. 
Socioeconomic and demographic factors that I analyze are different types of categorical 
data; nominal categorical data: religious affiliation and type of health insurance; ordinal 
categorical data: highest level of education; continuous data: age. 
Considering categorical independent and dependent outcomes and the purpose of 
the study, which is looking for correlations between the two, I am going to utilize Chi-
Square testing to analyze the data. Statistical analysis will be conducted using IBM 
version 24.0 Statistical Package for the Social Sciences software (SPSS) with a p-value of 
0.05. 
Data cleaning was previously completed to confirm that there were no data entry 
errors. To prevent any risk of bias, missing data will be excluded from the analysis. 
Therefore, the sample size might fluctuate due to the lack of response.  
 
 
Results  
 
Demographics  
 
Four hundred sixty-eight patients participated in the survey. This study focused on 
female patients only. Table 1 presents the demographics of the survey respondents. These 
participants were categorized into three groups: 64.1% (n=300) undergoing general 
gynecologic care, 22.4% (n=105) currently pregnant, and 13.5% (n=63) considering or 
receiving fertility treatments. The mean age was 30.03 ± 6.98 years with a range of 18-
63. The three groups were similar in age (see Table 1). The majority of women were 
Caucasian (77.4%; see Table 1).   
 
Table 1 Patient demographics and distribution (N=468) 
 
Demographic Proportion/Mean  
Patient type [%(n)]  
    General gynecology 64.1% (300) 
    Currently pregnant 22.4% (105) 
    Considering or receiving fertility treatment  13.5% (63) 
Average Age for Patient Type (mean ± SD)  
    General gynecology 30.21±7.65  
    Currently pregnant 28.51±5.05  
    Considering or receiving fertility treatment  31.67±5.89 
Gender  
    Female  100% (468) 
Ethnicity   
    Caucasian 77.4% (362) 
    African American  16.2% (76) 
    Caucasian-African American  0.6% (3) 
    Asian-Hispanic 1.3% (6) 
    Pacific Islander 0.2% (1) 
    Other 4.3% (20) 
 
Patients’ desire to undergo GCS based on socioeconomic and demographic factors 
 
 A greater number of patients in every age group did not desire to have GCS, 
compared to patients who did desire to have GCS. Of those in the 18-28 age group, 
43.6% (n=65) desired to undergo GCS while 56.4% (n=84) did not. For the 29-36 age 
group, 36.8% (n=57) desired to undergo GCS while 63.2% (n=98) did not. Among those 
whose age is greater than or equal to 37, even a greater proportion of patients 73.0% 
(n=46) did not wish to have GCS while only 27.0% (n=17) wished to have GCS. No 
significant relationship between patients’ age and their willingness to go through GCS 
was found (P=ns) (See Table 2).  
 Similarly, a greater number of patients responded that they would not like to 
undergo GCS, compared to the number of patients who did desire GCS, no matter what 
their insurance type was. Among those with private insurance, 36.2% (n=100) wished to 
go through GCS while 63.8% (n=176) did not. Of those with Medicaid 41.4% (n=36) 
desired GCS while 58.6% (n=51) did not. Self-pay patients were split in half in terms of 
their desire to go through GCS. Again, there was no significant relationship between 
respondents’ type of insurance and their desire to undergo GCS (P=ns) (See Table 2). 
Participants’ highest level of education did not affect their desire to have GCS 
(P=ns). Of those whose highest level of education was high school or GED, 38.6% 
(n=27) desired to undergo GCS while 61.4% (n=43) did not. Among participants whose 
highest level of education was some college, 36.6% (n=59) desired to go through the test 
while 63.4% (n=102) did not. Lastly, of patients whose highest level of education was 
graduate school or doctorate level, 40.0% (n=42) wished to go through GCS while the 
rest, 60.0% (n=63) did not wish to undergo GCS (See Table 2). 
Participants’ religious affiliation had a significant relationship with their desire to 
undergo GCS (P<0.05). Of those who are not religiously affiliated, 45.3% (n=53) 
answered that they desired the test while 54.7% (n=64) replied that they did not. 
However, among those who are religiously affiliated, 34.1% (n=86) desired to have the 
test while a significantly greater number of patients 65.9% (n=166) did not (See Table 2). 
Religiously affiliated patients were more likely to refuse GCS.  
Table 2 Patients’ desire to undergo GCS based on age, type of insurance, education level, 
and religious affiliation  
 
 Desire to Undergo GCS P  
Age [%(n)] Yes No <0.07 
    18-28 43.6% (65) 56.4% (84)   
    29-36 36.8% (57) 63.2% (98)  
    37+ 27.0% (17) 73.0% (46)  
Type of Insurance [%(n)]    <0.575 
    Private 36.2% (100) 63.8% (176)  
    Medicaid 41.4% (36) 58.6% (51)  
    Self Pay/None  50.0% (3) 50.0% (3)  
Education [%(n)]    <0.86 
    High School/GED 38.6% (27) 61.4% (43)  
    Some College 36.6% (59) 63.4% (102)  
    Graduate School/Doctorate Level  40.0% (42) 60.0% (63)  
Religiously Affiliated [%(n)]    <0.04 
    No  45.3% (53) 54.7% (64)  
    Yes 34.1% (86) 65.9% (166)  
 
 
Patients’ desire to undergo GCS based on previous pregnancy history  
 
Following analysis of the relationship between socioeconomic and demographic 
factors and desire to undergo GCS, previous pregnancy history was identified as another 
potential factor affecting patients’ desire to undertake GCS. Hence, a closer look at the 
relationship between participants’ previous pregnancy history and their willingness to go 
through GCS was performed. Those who desired to undergo GCS had a lower number of 
pregnancies and number of living children than those who did not desire to undergo GCS, 
but the groups were similar for number of miscarriages and elective abortions (see Table 
3).  
 In addition, those who had a previous abnormal ultrasound or abnormal prenatal 
testing were not more likely to report that they desired to undergo GCS (see Table 4).  
 
Table 3 Descriptive statistics of participants’ pregnancy history  
 
 Desire N Mean Std. Deviation P 
Number of Pregnancies Yes 140 1.24 1.644 <0.001 
No 237 1.84 1.775  
Number of Miscarriages Yes 139 0.36 0.780 <0.82 
No 234 0.38 1.099  
Number of Elective Abortion Yes 136 0.12 0.405 <0.99 
No 231 0.12 0.437  
Number of Living Children Yes 138 0.64 1.139 <0.001 
No 235 1.11 1.160  
 
Table 4 Patients’ desire to undergo GCS based on history of abnormal ultrasound and 
prenatal screening in a previous pregnancy  
 
 Desire to Undergo GCS P  
Abnormal Ultrasound [%(n)] Yes No <0.10 
    Yes 41.2% (7) 58.8% (10)   
    No 37.7% (126) 62.3% (208)  
Abnormal Prenatal Screening [%(n)]   <0.35 
    Yes 53.8% (7) 46.2% (6)  
    No 37.6% (126) 62.4% (209)  
 
Participants’ attitudes toward GCS 
 
 The majority of patients reported a positive or neutral attitude toward GCS; only 
nine patients had negative attitude toward GCS (See Table 5). However, interestingly, a 
larger number of participants did not wish to have GCS for every sub-group that was 
examined.  
 
Table 5 Participant’s attitudes toward GCS (N=466) 
 
Attitudes toward GCS [%(n)] 
Positive  Negative  Neutral  Unsure  
45.9% (214) 1.9% (9) 47.6% (222) 4.5% (21) 
 
Currently pregnant patients’ desire to undergo GCS  
 
We further explored the subgroup of “Currently pregnant” patients’ responses to 
determine whether “currently pregnant” patients might have a greater interest in learning 
about their fetus’ health and potential genetic disorders. “Currently pregnant” patients’ 
age, type of insurance, and religious affiliation did not have a significant association with 
their desire to go through GCS (see Table 6). H highest level of education was 
significantly related to their wish to undergo GCS with women having a higher level of 
education being less likely to desire GCS (p<0.05).   
 
Table 6 Desire to undergo GCS based on age, type of insurance, education level, and 
religious affiliation (N=82) among women who were currently pregnant 
 
 Desire to Undergo GCS P   
Age [%(n)] Yes No <0.66 
    18-28 28.1% (9) 71.9% (23)   
    29-36 23.4% (11) 76.6% (36)  
    37+ 50.0% (1) 50.0% (4)  
Type of Insurance [%(n)]   <0.28 
    Private 21.7% (13) 78.3% (47)  
    Medicaid 38.1% (8) 61.9% (13)  
    Self Pay/None  0.0% (0) 100.0% (1)  
Education [%(n)]   <0.05 
    High School/GED 46.7% (7) 53.3% (8)  
    Some College 12.9% (4) 87.1% (27)  
    Graduate School/Doctorate Level  27.6% (8) 72.4% (21)  
Religiously Affiliated [%(n)]   <0.77 
    No  27.6% (8) 72.4% (21)  
    Yes 24.5% (13) 75.5% (40)  
 
Discussion   
We found there was no difference in the desire to undergo GCS related to age, 
type of insurance, or highest level of education. However, when only currently pregnant 
women were examined, those with at least some college were less likely to desire to 
undergo GCS than women with high school as their highest level of education. Previous 
studies have shown that patients with higher education tend to worry more about the 
possibility of eugenics and the use of new biotechnology in medicine than others [29-30]. 
However, numerous studies have shown that high socioeconomic status with higher 
educational level and income are associated with a greater acceptance of GCS [31-36]. 
Additionally, studies show that women with higher education are more favorable toward 
abortion compared to other women when they are at risk of sacrificing their career [37].  
This study shows that women who reported having a religious affiliation were less likely 
to desire GCS than women reporting no religious affiliation. Previous studies support that 
religiously affiliated patients, no matter of their affiliated religion or ethnicity, do not 
consider terminating the pregnancy as an option in case of an affected child because of 
their faith [28-40]. This is not surprising because religions have a quite consolidated view 
on preserving and protecting life. And patients with religious beliefs are more likely to 
have a bigger support system that can certainly help them emotionally and spiritually [41-
43]. 
 Another study shows that even though a majority of Lutheran pastors believe that 
genetic counseling is beneficial and like to be involved in the decision-making process of 
family planning, they do not regard abortion as an option for the fetus with Huntington 
disease and Down syndrome [44]. However, many of the patients agree that termination 
may be allowed in case of legal issues such as rapes are involved or when the mother’s 
life is in danger [38]. 
The positive correlation between educational attainment and religious services 
attendance might explain the unwillingness of patients with a higher education and 
religious belief to go through GCS [45]. Also, patients with higher level of education are 
more likely to have more means to raise children with special needs. 
Women with fewer pregnancies and fewer living children are more likely to 
desire GCS. There have been studies that found the same: patients with fewer or no 
children are more likely to undertake GCS out of uncertainty and worry about their 
pregnancy [34,46]. Having previous abnormal ultrasound or prenatal testing did not 
change their desire to have GCS compared to those without this history. There is no study 
to explain this finding, and this undermines the idea of the perceived threat that will be 
discussed later.  
The majority of women reported a positive or neutral attitude toward GCS, 
however, their desire to undertake GCS was low.  
This inconsistency between patients’ attitudes and behavior toward GCS seems to 
be common among patients. [8,12, 47-49]. It can be possibly explained by patients’ 
perceived threat. The perceived threat is a measure of how much risk an individual 
believes that he or she might have a trait for genetic diseases. If a patient has direct or 
distant family members with genetically transmitted health conditions, his or her 
perceived threat is likely to be higher compared to others with no family history of 
inheritable illnesses. How much they know about the severities and consequences of 
those diseases might affect their perceived threat as well. Patients with a greater 
perceived threat are more likely to agree to have GCS for both inheritable and other 
nonheritable disorders [20,28]. On the other hand, patients with low perceived threat 
would be less willing to have GCS even if they do not necessarily have negative opinions 
regarding GCS. 
Participants’ perceived norm might be another explanation for the discrepancy 
observed between their attitudes and behavior [28,50-52]. Perceived norm is the 
perceived social pressure to perform or not to perform certain behaviors [52]. 
Respondents are likely to be aware of the controversy over GCS due to ethical and moral 
responsibilities. Just being aware of this negative connotation and impression about GCS 
is likely to affect patients’ decision when it comes to undergoing GCS. Even though 
patients might not have negative opinions on GCS, they might be concerned of being 
judged by their family members, friends, or even general public to undergo GCS.  
 Lastly, respondents’ fear that GCS might result in unnecessary feelings of guilt 
and a greater amount of burden to them as parents might prevent them from taking GCS 
[17]. Patients and their partners, who do not wish to live with the distress sprung from the 
knowledge of their carrier status, support the “right to not know.” They believe that if 
nothing can be altered about their carrier status, knowing their carrier status would result 
in a tremendous amount of anxiety and stress with no solution to it [48-49]. 
 
Limitations 
 
The study has several limitations. This was a secondary analysis of existing data 
with a questionnaire developed previously for another study. The questionnaire does not 
include ways to measure content validity or internal consistency. However, the question 
that measures participant’s desire to go through GCS was clearly worded as “Do you 
desire to undergo Genetic Carrier Screening?” with “Yes” and “No.” Therefore, it meets 
face validity.  
The data were collected via self-report of a convenience sample, and most 
participants identified themselves as Caucasian females with Christian faith living in 
Ohio. Therefore, the data might include respondent bias and be difficult to apply to the 
general population. This study was a cross-sectional study in which analysis of causation 
or changes over an extended length of time would not be applicable. Lastly, employment 
status or income of participant could have assessed their socioeconomic status but were 
not included in this study. 
We examined patients’ pregnancy history and its relationship with willingness to 
undergo GCS. In addition, there could be different variables (i.e. ethnicity, cultural 
norms) that this study did not examine but may influence participants’ desire to have 
GCS. Investigating these other confounding variables would be the next step in further 
exploring the utility of GCS. Exploring association of respondents’ perceived threat and 
norm and their decision regarding GCS will be able to provide further and deeper 
understanding of this study’s results.  
Conclusion 
  
 Awareness of the association between religious belief and desire to undergo GCS 
can help physicians prepare for conversations with patients about GCS. While education 
level was not associated with the desire to undergo GCS in the overall group of patients, 
women who were currently pregnant were less likely to desire GCS with increasing 
levels of education. Few patients had a negative attitude toward GCS, although attitudes 
toward GCS were not related to reported desire to undergo GCS. Future research may 
include examination of the relationship of other factors, such as medical history, 
pregnancy history, and cultural norms, and GCS. Understanding the influence of other 
factors on the desire for GCS is important not only to reconcile the gap between benefits 
and patient use of GCS but also to build stronger patient-physician rapport.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A Patient Survey  
 
THIS SURVEY ASKS QUESTIONS THAT MAY BE SENSITIVE IN NATURE. THESE QUESTIONS 
ARE THEORETICAL, AND ITS INTENTION IS NOT TO OFFEND OR IMPLY THAT GENETIC 
CARRIER SCREENING WILL BE USED IN THIS WAY.  
 
WE ARE INTERESTED IN SEEKING YOUR OPINION ABOUT THE POTENTIAL WAYS THAT THIS 
TYPE OF SCREENING COULD BE USED IN THE FUTURE. YOU CAN RESPOND TO AS FEW, OR 
AS MANY QUESTIONS AS YOU WOULD LIKE TO.  
 
BY COMPLETING THE SURVEY, YOU ARE CONSENTING TO PARTICIPATION IN THIS 
RESEARCH. WE WILL NOT HAVE ANY WAY OF IDENTIFYING YOU BASED ON THE ANSWERS 
YOU GIVE TO THE SURVEY. THE DATA COLLECTED FROM THIS RESEARCH WILL NOT BE 
USED TO IMPLEMENT POLICY THAT WILL ALTER INSURANCE COVERAGE. IF YOU HAVE 
ANY QUESTIONS REGARDING THE SURVEY, PLEASE TEAR OFF THE BACK PAGE WHERE 
YOU WILL FIND CONTACT INFORMATION FOR THE INVESTIGATORS CONDUCTING THIS 
RESEARCH. 
 
Please answer all questions to the best of your ability. 
 
NOTE: definitions are provided for medical terms. All defined terms are bolded. 
The end of the survey has all definitions listed in alphabetical order. 
 
Full Disclosure: There are some sensitive topics covered in this study including 
abortion. The Researchers conducting this study do not support any specific 
viewpoints (positive or negative) regarding this or other sensitive topics.  
 
 
1. Age: ______ 
 
2. Gender: Female Male 
 
3. Ethnic group: Caucasian African American Asian Hispanic Pacific Islander Other: 
______________ 
 
4. Education: High School GED Some College Graduate school Doctoral degree  
Other: _______________ 
 
5. Geographic location: 
Please specify State: __________________ 
 
6. Type of medical insurance: Private Medicaid Self Pay/none 
 
7. Religious preference: Catholicism Protestantism Judaism Islam Buddhism Hinduism  
No religious affiliation Other: _______________ 
 
8. Please provide numbers for your pregnancy history. 
number of pregnancies: ___________ (regardless of outcome, and include current) 
number of miscarriages? ____________ 
number of elective abortions? ________ 
number of living children: ___________ 
 
9.Are you currently pregnant? Yes No 
 
10. Do you currently use contraception?  
Yes No If yes, what type?_______________ 
 
11.Please select the category that most closely defines your current reproductive status. 
 Sexually active with no intention of having a child in the near future  
 Sexually active, willfully not using contraception, but uncertain about wanting to have a child in the 
near future or wishing to leave it to chance 
 Sexually active, with a partner whom I know I cannot produce a child with. For example, you are both 
the same sex or one or both of you cannot have children. 
Sexually active with the intention of having a child in the near future 
 
12. Were you aware of Genetic Carrier Screening prior to your appointment today? 
 Yes No Unsure why?:_______________________ 
 
13.If you answered yes to #12, please select the source from which you received this information. 
 commercial media (TV, computer, billboards, etc.) 
 OB/GYN 
 genetics counselor 
 fertility doctor 
 other, please specify_______________________ 
 
14. Did you understand the material provided to you prior to this survey? 
 Yes No Unsure why?: _____________________________ 
 
15. After reading the material, do you desire to undergo Genetic Carrier Screening? 
 Yes No Unsure why?:_____________________________ 
 
16. If you are a genetic carrier for a disease, what would you choose to do next?  Please select one option. 
 Would have my partner screened 
 Nothing, would not change plans 
 Would choose to undergo In Vitro Fertilization (IVF)  
 Would only choose prenatal screening in pregnancy  
 Other (Please specify): _______________ 
17. Have you had a history of any of the following? Please answer Yes/No. 
More than 2 miscarriages 
 Yes No Unsure why?: _____________________________ 
 
Child with a genetic disease/disorder?  
 Yes (if yes, please specify what disease/disorder)____________ 
 No Unsure why?: _____________________________ 
 
Abnormal ultrasound in a previous pregnancy? 
 Yes No Unsure why?: _____________________________ 
 
Abnormal Prenatal Screening (Quad screen, First Trimester screen, Non invasive prenatal screening) in a 
previous pregnancy? 
 Yes No Unsure why?: _____________________________ 
 
Amniocentesis or Chorionic Villi Sampling (CVS) in a previous pregnancy? 
 Yes No Unsure why?: _____________________________ 
 
 
18. Generally, how do you feel about genetic carrier screening?  
 Positive  
 Negative  
 Neutral  
 Unsure why?: _____________________________ 
 
19. Which of the following providers do you feel could adequately counsel you on the risks and benefits of 
genetic carrier screening and explain the results of the test? Please select all that apply. 
 Primary OB doctor 
 High risk OB doctor 
 Reproductive Endocrinologist doctor 
 Family Practice doctor 
 Genetics counselor 
 Nurse midwife 
 Nurse Practitioner 
 I am not interested in being counseled by anyone 
 Other (Please Specify): ___________________________ 
 
20. Considering your medical history and family history, do you feel genetic carrier screening should be 
performed before any other testing? 
 Yes No Unsure,  
If yes, please explain why.: _____________________________ 
 
21. Do you feel that genetic carrier screening should be available to all fertility patients, defined as 
women undergoing treatment with assisted reproductive technologies? 
 Yes No Unsure why?: _____________________________ 
 
22. Do you feel that insurance should cover genetic carrier screening to women undergoing treatment 
with assisted reproductive technologies? 
 Yes No Unsure why?: _____________________________ 
 
23. Do you feel that genetic carrier screening should be offered to all pregnant women? 
 Yes No Unsure why?: _____________________________ 
 
24. Do you feel that genetic carrier screening should be offered to all women of reproductive age 
regardless of whether they are actively trying to conceive? 
 Yes No Unsure why?: _____________________________ 
 
25. Which potential traits would you be interested in testing for by genetic carrier screening if they 
became available? Please check all that apply. 
  Inheritable disease (for example, cystic fibrosis or sickle cell) 
 Autism 
 Complex disease, such as diabetes or lupus 
 Psychiatric conditions, such as depression or schizophrenia 
 Adult-onset inheritable disease, such as breast or colon cancer 
 Personality disorders, such as obsessive-compulsive disorder or oppositional defiant disorder 
 I would not be interested in any of these options 
 
26. Do you feel that doctors have a moral obligation to support limits on the genetic carrier screening that 
is available to you? 
 Yes No Unsure  
Please explain your answer. 
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
_________________________ 
 
27. Considering cost, when would you do genetic carrier screening? Check all that apply. 
 if your insurance covered the testing?   
 if insurance required a copay 
 if insurance did not cover the testing 
 
 
28. How much would you be willing to pay for genetic carrier screening as insurance does not currently 
cover the test? 
 I would not pay out of pocket 
  $50-100 
  $150-250 
  $300-500 
  $>500 
29. What would lead you to have an abortion? Please check all that apply. 
 I would NEVER get an elective abortion 
 Diagnosed with fetal condition where survival is unlikely 
 Diagnosed with severe fetal anomalies but survival is likely with severe disability 
 Diagnosed with minor fetal anomalies and survival is likely with minor disability 
 Unsure what I would do 
 Other (please 
explain);____________________________________________________________________ 
 
30.Please select which of the following statements more closely describes how you feel. 
 I feel that finding out the results of a genetic test that could reveal I have a chance of passing on a 
disease to a child such as cancer, heart disease, diabetes, other major illnesses or genetic diseases would 
cause me to worry excessively and be a greater burden than not knowing. 
I feel that it would be more beneficial to know the chance I have to pass on an illness to a child so I can 
try to prevent future children from having disease. 
 
31.Please select which of the following statements more closely describes how you feel 
A potential mother has a responsibility to do everything in her power to make certain her child does not 
suffer; this includes any genetic testing available to screen for potential illness. 
 Regardless of the potential outcome for the offspring, the ability for the mother to choose to have 
genetic testing or not is more important. Without this ability, the mother is viewed as less important than 
the potential child she will have. 
 
Definitions 
 
Abortion: The act of choosing to end a pregnancy, during the first 28 weeks. 
Amniocentesis: A test your OB/GYN does between 14-16 weeks of pregnancy to detect an abnormal baby, 
such as one with Down Syndrome. 
Chorionic Villi Sampling (CVS): A test your OB/GYN does between weeks 10-12 of pregnancy to detect 
an abnormal baby, such as one with Down Syndrome. 
Copay: A payment agreement where the patient pays a certain amount and the insurance company pays the 
rest of the amount.  
Genetic carrier: Someone who has a risk of passing a genetic abnormality to their children as determined 
by testing. 
Genetic Carrier Screening: A test you can have before becoming pregnant to determine your chances of 
having an abnormal baby due to a genetic problem. 
In Vitro Fertilization (IVF): A procedure that involves a fertility doctor who can harvest your eggs, 
fertilize them with sperm outside of your body, then put one or more of them back into your body to help 
you have a child. 
Miscarriage: This occurs when a baby dies early in pregnancy (before the 20th week). 
Prenatal Screening: Testing done once you are already pregnant to determine if the baby has any specific 
abnormalities including Down Syndrome. 
Ultrasound: A medical instrument that the OB/GYN places on your tummy to look at your developing 
baby. 
Quad Screen: A test your OB/GYN does between weeks 15-20 of pregnancy that can detect an abnormal 
baby, such as one with Down Syndrome or with an abnormal spine. 
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